FACULTY


IMMUNOTHERAPY BRIDGE
December 5, 2015



Maria Libera Ascierto
Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland

Alfredo Budillon
Experimental Pharmacology Unit, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Filippo de Braud
National Cancer Institute of Milan, Italy

Silvia Formenti
Department of Radiation Oncology, Weill Cornell Medical College, New York

Sacha Gnjatic
Tisch Cancer Institute, Hematology/Oncology, Immunology, Icahn School of Medicine at Mount Sinai, New York

Cesare Gridelli
“S.G. Moscati” Hospital, Avellino, Italy

Hans Joerg Hammers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Vera Hirsh
McGill University, Royal Victoria Hospital, Montreal, Canada

Rolf Kiessling
Karolinska Institutet, Stockholm, Sweden

Ignacio Melero
CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain

Rita Nanda
Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois

Graham Pawelec
Second Deperment of Internal Medicine, University of Tuebingen, Tuebingen, Germany

Sandro Pignata
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Pedro Romero
Ludwig Center for Cancer Research, University of Lausanne, Switzerland

Daniel Speiser
Department of Oncology and Ludwig Cancer Research Center, University of Lausanne, Switzerland


* To be confirmed



For information please contact info@melanomabridge.org